Ashley McEvoy

Ashley McEvoy is the President & Chief Executive Officer of Insulet Corporation, an experienced healthcare executive and Board member. From 1996 to 2023, she served in leadership roles of increasing responsibility at Johnson & Johnson, most recently as Executive Vice President and Worldwide Chairman of Johnson & Johnson’s MedTech business, an organization with 60,000 global employees and revenue of more than $30 billion. In that role, she accelerated revenue growth while expanding the business’s presence in higher growth markets and doubling the value of the business’s new product pipeline. Earlier in her tenure at Johnson & Johnson, she served as Company Group Chairman of Vision and Diabetes Care for six years, Worldwide President of Ethicon Inc. for three years, and President of McNeil Consumer Healthcare for three years, among other leadership roles. Since 2023, Ashley has been a member of the Procter & Gamble Board of Directors, serving on the Compensation & Leadership Development and Innovation & Technology Committees. She previously served on the Board of Trustees for the Children’s Hospital of Philadelphia. Ashley has been named to FORTUNE’s “Future Fortune 500 CEOs” list and Forbes’ inaugural “CEO Next” list. In 2019, she was named to FORTUNE’s “Most Powerful Women” list, and she was also recognized as a Woman of Achievement by the National Association of Female Executives the following year. She also ranked #1 on The Healthcare Technology Report’s “Top 25 Women Leaders in Medical Devices” list in 2021. A Philadelphia native and graduate of the University of Pennsylvania, Ashley is a mother of five children and one Siberian husky and enjoys staying active with family, friends, and colleagues.